You run a 10-year plan for the company and a day-by-day one for your body

You have a rigorous framework for every major decision at work. Go-To-Market Strategy. Product Roadmap. Customer Lifetime Value. Tail risks. A plan that looks ten years out and works backwards.

Point that same brain at your own mortality, and most high-functioning people are running… nothing. Or worse — a reactive maintenance cycle. Something breaks, you fix it. A number goes red, you treat it. Feel fine, do nothing.

That cycle has a name: Medicine 2.0. Wait for the problem, then act on it. It is genuinely brilliant at acute things — a broken leg, an infection. But it is structurally too late for the things most likely to take you out, because those aren’t just events. They’re slow processes, often decades underway before they ever surface on a standard test. “Not sick yet” is the default reading — right up until you are.

Medicine 3.0 is the upgrade. And the punchline is that it isn’t exotic: it’s the same discipline you already use professionally — proactive, personalized, playing the long game. It doesn’t wait for the diagnosis. It manages the risk, years upstream, while you can still move it. (Peter Attia makes the full case in Outlive; this is the operator’s-eye version.)

So run the diligence. If you were pricing the real risks to your own life, there are four critical positions on the register that matter for anyone who doesn’t smoke — a “Chronic Quartet” that accounts for the overwhelming majority of mortality in non-smokers:

→ Cardiovascular disease — the single leading cause of death on earth.

→ Cancer.

→ Neurodegenerative disease — Alzheimer’s and related dementias.

→ Metabolic dysfunction — type 2 diabetes and everything that precedes it.

Here’s the part that changes how you’d allocate. Three of those are direct drivers of mortality. The fourth — metabolic dysfunction — is the soil. It quietly accelerates the other three. But you can move early, predictably and often only with lifestyle interventions. The uncomfortable base rate: in the U.S., only about 12% of adults are metabolically healthy across every marker (Araújo et al., 2019). Singapore gets no free pass — at least 1 in 5 adults here meet the criteria for full metabolic syndrome (Ranasinghe et al., 2017), and because body-fat rises faster than BMI in Asian populations, that dysfunction routinely hides inside lean, normal-weight professionals. “Not sick” is not the same as healthy — and that gap is the single biggest leverage point most people never touch.

One more reframe, because it decides what you’re even optimizing for — and it isn’t a trade-off. You want both: lifespan, the years, and healthspan, the capacity you carry through them. For most people that’s a quality-of-life point. For an operator it’s sharper than that: you are the single point of failure in your company. Everything runs downstream of your judgment under load, your energy in the twelfth hour, whether you’re still sharp and in the room in year ten of the build. Peak performance across decades isn’t vanity — it’s key-man risk, and the key man is you. Lifespan keeps you in the game. Healthspan keeps you at the top of it — performing at your ceiling, and there for the people counting on you — across the decades that actually decide the outcome.

That’s one key part of the framework: The four things that actually take people down, and where your risk truly sits. The Halor app will turn it from a diagram into your plan, with the exact questions to bring to your physician and the protocols to execute.

You’re the CEO of a decades-long project. Your physician is your highest-value consultant. Halor is the co-pilot that keeps the whole healthspan plan in front of you.

If this reframed how you think about the long game, forward it to someone who runs a brilliant ten-year plan for everything except themselves.

— Ben

P.S. Of the Chronic Quartet, which one actually worries you — and which have you done anything about? They’re rarely the same one. Reply and tell me; it shapes what gets written next.